Ledger.Open graph →
SEC Form D · filed February 7, 2019

Axon Therapies Inc

Offering
$150.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Sean Madnani · Los Angeles, CADirectorBradley M. Anderson · New York, NYDirectorSteven S. Hochberg · New York, NYDirectorAndre Bliznyuk · Tarzana, CADirectorDavid Pakman · New York, NYDirectorMark R. Gelfand · New York, NYExec · DirectorMitchell S. Bloom · New York, NYExecImran S. Eba · New York, NYDirectorNicolai Wadstrom · San Francisco, CAExec · DirectorChris Carvalho · Tarzana, CADirectorPaul S. Laviolette · New York, NYDirectorWadstrom Nicolai · San Francisco, CAExec · DirectorCarl J. Tippit · Cleveland, OHExecRobert A. Granieri · New York, NYExecAndrew S. Elbardissi · New York, NYDirectorBenjamin Levy · San Francisco, CAExec · DirectorDavid Dunn · Wilton, CTDirectorAdi Sideman · New York, NYDirectorPatrick Ritschel · Durham, NCDirectorRagan Young · Dallas, TXExec · DirectorHoward R. Levin · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗